Juxtascleral drug delivery and ocular implant system

Details Juxtascleral drug delivery and ocular implant system Juxtascleral drug delivery and ocular implant system

2011-03-22

2011-03-22

Stigell, Theodore J (Department: 3763)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S181000, C604S244000

Reexamination Certificate

active

07909800

ABSTRACT:
Ophthalmic drug delivery devices useful for delivery of pharmaceutically active agents to the posterior segment of the eye are disclosed.

REFERENCES:
patent: 2022065 (1935-11-01), Wappler
patent: 2591457 (1952-04-01), Maynes
patent: 4900303 (1990-02-01), Lemelson
patent: 4968296 (1990-11-01), Ritch et al.
patent: 4990135 (1991-02-01), Truesdale, Jr.
patent: 5167641 (1992-12-01), Schmitz
patent: 5242449 (1993-09-01), Zaleski
patent: 5702414 (1997-12-01), Richter et al.
patent: 6283949 (2001-09-01), Roorda
patent: 6397849 (2002-06-01), Bowman et al.
patent: 6899717 (2005-05-01), Weber et al.
patent: 2005/0143363 (2005-06-01), De Juan et al.
patent: 2009/0012595 (2009-01-01), Seliktar et al.
patent: 02089767 (2002-11-01), None
patent: 03000312 (2003-01-01), None
Guttman, “Cannula approach using posterior delivery brings unparalleled safety”; Ophthalmology Times, Mar. 1, 2003, 2 pgs.
Peterson, L., “Age-Related Macular Degeneration”; Trends-in-Medicine, May 2002, 6 pgs.

Affiliated with

Also associated with

Rating

Juxtascleral drug delivery and ocular implant system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Juxtascleral drug delivery and ocular implant system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Juxtascleral drug delivery and ocular implant system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2725570